284 related articles for article (PubMed ID: 12669028)
1. Challenges for the oral delivery of macromolecules.
Goldberg M; Gomez-Orellana I
Nat Rev Drug Discov; 2003 Apr; 2(4):289-95. PubMed ID: 12669028
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
4. Commercial challenges of protein drug delivery.
Brown LR
Expert Opin Drug Deliv; 2005 Jan; 2(1):29-42. PubMed ID: 16296733
[TBL] [Abstract][Full Text] [Related]
5. Challenges to macromolecular drug delivery.
Juliano R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
[TBL] [Abstract][Full Text] [Related]
6. [Endocytosis mediated by receptors--function and participation in oral drug delivery].
Zuwała-Jagiełło J
Postepy Hig Med Dosw; 2003; 57(3):275-91. PubMed ID: 14524247
[TBL] [Abstract][Full Text] [Related]
7. Liphophilic complexation of heparin based on bile acid for oral delivery.
Lee DY; Lee J; Lee S; Kim SK; Byun Y
J Control Release; 2007 Oct; 123(1):39-45. PubMed ID: 17765350
[TBL] [Abstract][Full Text] [Related]
8. Low-frequency sonophoresis: current status and future prospects.
Ogura M; Paliwal S; Mitragotri S
Adv Drug Deliv Rev; 2008 Jun; 60(10):1218-23. PubMed ID: 18450318
[TBL] [Abstract][Full Text] [Related]
9. Sonophoresis: recent advancements and future trends.
Rao R; Nanda S
J Pharm Pharmacol; 2009 Jun; 61(6):689-705. PubMed ID: 19505359
[TBL] [Abstract][Full Text] [Related]
10. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
Gursoy RN; Benita S
Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal patch systems for oral drug delivery.
Tao SL; Desai TA
Drug Discov Today; 2005 Jul; 10(13):909-15. PubMed ID: 15993810
[TBL] [Abstract][Full Text] [Related]
12. Principles of transmucosal delivery of therapeutic agents.
Blanchette J; Kavimandan N; Peppas NA
Biomed Pharmacother; 2004 Apr; 58(3):142-51. PubMed ID: 15082336
[TBL] [Abstract][Full Text] [Related]
13. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Sudhakar Y; Kuotsu K; Bandyopadhyay AK
J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
[TBL] [Abstract][Full Text] [Related]
14. Recombinant therapeutic proteins: production platforms and challenges.
Dingermann T
Biotechnol J; 2008 Jan; 3(1):90-7. PubMed ID: 18041103
[TBL] [Abstract][Full Text] [Related]
15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
16. Is the oral route possible for peptide and protein drug delivery?
Morishita M; Peppas NA
Drug Discov Today; 2006 Oct; 11(19-20):905-10. PubMed ID: 16997140
[TBL] [Abstract][Full Text] [Related]
17. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
Juliano RL; Astriab-Fisher A; Falke D
Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
[TBL] [Abstract][Full Text] [Related]
18. Oral strip technology: overview and future potential.
Dixit RP; Puthli SP
J Control Release; 2009 Oct; 139(2):94-107. PubMed ID: 19559740
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of heparin: SNAC and related formulations.
Pineo G; Hull R; Marder V
Best Pract Res Clin Haematol; 2004 Mar; 17(1):153-60. PubMed ID: 15171964
[TBL] [Abstract][Full Text] [Related]
20. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
